Sugammadex is the first selective relaxant binding agent and reverses rocuronium-induced neuromuscular block. A case is reported in which a patient accidentally received a high dose of sugammadex (40 mg kg-1) to reverse a rocuronium-induced (1.2 mg kg-1) profound neuromuscular block. A fast and efficient recovery from profound neuromuscular block was achieved and no adverse events or other safety concerns were reported.

, ,
doi.org/10.1093/bja/aem057, hdl.handle.net/1765/35464
British Journal of Anaesthesia
Erasmus MC: University Medical Center Rotterdam